Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population

OBJECTIVE: To determine multiple sclerosis patient characteristics that predict a shorter duration of natalizumab treatment. METHODS: The Tysabri Outreach: Unified Commitment to Health database was reviewed to identify patients treated with natalizumab at our centers. Cox proportional hazards models...

Descripción completa

Detalles Bibliográficos
Autores principales: Conway, Devon S, Hersh, Carrie M, Harris, Haleigh C, Hua, Le H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987494/
https://www.ncbi.nlm.nih.gov/pubmed/32064117
http://dx.doi.org/10.1177/2055217320902488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987494/
https://www.ncbi.nlm.nih.gov/pubmed/32064117
http://dx.doi.org/10.1177/2055217320902488

Ejemplares similares